Skip to main content
Advertisement
Advertisement

ABVX

ABVX logo

Abivax SA - ADR

102.23
USD
Sponsored
-4.43
-4.15%
Sep 16, 15:59 UTC -4
Closed
exchange

After-Market

102.80

+0.56
+0.55%

ABVX Earnings Reports

Positive Surprise Ratio

ABVX beat 2 of 6 last estimates.

33%

Next Report

Next Week
Date of Next Report
Sep 21, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.55M
/
-$1.82
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
+22.18%
/
+14.47%

Abivax SA - ADR earnings per share and revenue

On May 25, 2026, ABVX reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -1.82 USD, with revenue projected to reach 2.55 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
logo
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
logo
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
For Q1 2026, Abivax SA - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Sep 21, 2026.
Based on -- analysts, Abivax SA - ADR is expected to report EPS of -$1.82 and revenue of $2.55M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement